P

PTC Therapeutics
D

PTCT

46.200
USD
1.00
(2.21%)
مغلق
حجم التداول
0
الربح لكل سهم
-5
العائد الربحي
-
P/E
-8
حجم السوق
3,563,181,607
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ABUS
    0.01000
    (0.31%)
    3.20000 USD
    A
    ARCT
    0.680
    (4.59%)
    15.500 USD
    A
    ARWR
    -0.020
    (-0.10%)
    19.450 USD
    C
    CRNX
    0.820
    (1.56%)
    53.520 USD
    C
    CRSP
    0.360
    (0.89%)
    40.720 USD
    G
    GLPG
    0.380
    (1.44%)
    26.730 USD
    R
    RARE
    0.770
    (1.77%)
    44.190 USD
    S
    SLDB
    0.14500
    (3.62%)
    4.15000 USD
    S
    SRPT
    -0.470
    (-0.39%)
    118.970 USD
    V
    VKTX
    0.780
    (1.88%)
    42.270 USD
    V
    VYGR
    0.06000
    (1.05%)
    5.76000 USD
    المزيد
الأخبار

العنوان: PTC Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
PTC Therapeutics Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when an RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology.